IN2014DN10680A - - Google Patents
Download PDFInfo
- Publication number
- IN2014DN10680A IN2014DN10680A IN10680DEN2014A IN2014DN10680A IN 2014DN10680 A IN2014DN10680 A IN 2014DN10680A IN 10680DEN2014 A IN10680DEN2014 A IN 10680DEN2014A IN 2014DN10680 A IN2014DN10680 A IN 2014DN10680A
- Authority
- IN
- India
- Prior art keywords
- polymorphic forms
- crystalline polymorphic
- respiratory
- disease
- mdt
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0012—Galenical forms characterised by the site of application
- A61K9/007—Pulmonary tract; Aromatherapy
- A61K9/0073—Sprays or powders for inhalation; Aerolised or nebulised preparations generated by other means than thermal energy
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
- A61P11/02—Nasal agents, e.g. decongestants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P27/00—Drugs for disorders of the senses
- A61P27/16—Otologicals
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/12—Antivirals
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/12—Antivirals
- A61P31/14—Antivirals for RNA viruses
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D257/00—Heterocyclic compounds containing rings having four nitrogen atoms as the only ring hetero atoms
- C07D257/02—Heterocyclic compounds containing rings having four nitrogen atoms as the only ring hetero atoms not condensed with other rings
- C07D257/04—Five-membered rings
Abstract
The present invention provides novel crystalline polymorphic forms of MDT 637 in particular crystalline polymorphic forms with physicochemical properties specifically suited for drug production amorphous formation composite form and methods of preparation thereof. The novel polymorphs described herein are useful for the treatment of respiratory disease such as disease caused by respiratory syncytial virus.
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US201261666258P | 2012-06-29 | 2012-06-29 | |
PCT/US2013/048723 WO2014005098A2 (en) | 2012-06-29 | 2013-06-28 | Compositions and methods for treating or preventing pneumovirus infection and associated diseases |
Publications (1)
Publication Number | Publication Date |
---|---|
IN2014DN10680A true IN2014DN10680A (en) | 2015-08-28 |
Family
ID=49778754
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
IN10680DEN2014 IN2014DN10680A (en) | 2012-06-29 | 2013-06-28 |
Country Status (17)
Country | Link |
---|---|
US (2) | US9040569B2 (en) |
EP (1) | EP2867216A4 (en) |
JP (1) | JP2015524391A (en) |
KR (1) | KR20150037946A (en) |
CN (1) | CN104507918A (en) |
AU (1) | AU2013282286A1 (en) |
BR (1) | BR112014032290A2 (en) |
CA (1) | CA2877941A1 (en) |
EA (1) | EA201590124A1 (en) |
HK (2) | HK1203956A1 (en) |
IL (1) | IL236476A0 (en) |
IN (1) | IN2014DN10680A (en) |
MX (1) | MX2014015340A (en) |
NZ (1) | NZ628880A (en) |
TW (1) | TWI516283B (en) |
WO (1) | WO2014005098A2 (en) |
ZA (1) | ZA201409073B (en) |
Families Citing this family (5)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
IN2014DN10680A (en) | 2012-06-29 | 2015-08-28 | Microdose Therapeutx Inc | |
CN107567437B (en) * | 2014-12-18 | 2020-11-17 | 麦翠奥制药公司 | Crystalline form of 5-amino-2, 3-dihydrophthalazine-1, 4-dione sodium salt, pharmaceutical preparation containing it and process for its production |
WO2017095905A1 (en) * | 2015-11-30 | 2017-06-08 | Flesher Gregory J | Compositions and methods for otologic prophylaxis and treatment |
WO2018071435A1 (en) | 2016-10-11 | 2018-04-19 | Microdose Therapeutx, Inc. | Inhaler and methods of use thereof |
US20200085741A1 (en) * | 2018-09-14 | 2020-03-19 | Pharmosa Biopharm Inc. | Pharmaceutical composition for controlled release of weak acid drugs and uses thereof |
Family Cites Families (6)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
EP1051169A4 (en) * | 1998-01-29 | 2002-05-29 | Viropharma Inc | Compounds, compositions and methods for treating or preventing pneumovirus infection and associated diseases |
US6495580B1 (en) | 1998-01-29 | 2002-12-17 | Viropharma Incorporated | Compounds, compositions and methods for treating or preventing pneumovirus infection and associated diseases |
WO2002059132A1 (en) | 2001-01-26 | 2002-08-01 | Viropharma Incorporated | Intermediate compounds useful for making antiviral compounds |
CA2495245A1 (en) | 2002-08-09 | 2004-02-19 | Viropharma Incorporated | Compounds, compositions and methods for treating or preventing pneumovirus infection and associated diseases |
CA2495266A1 (en) | 2002-08-09 | 2004-02-19 | Viropharma Incorporated | Compounds, compositions and methods for treating or preventing pneumovirus infection and associated diseases |
IN2014DN10680A (en) | 2012-06-29 | 2015-08-28 | Microdose Therapeutx Inc |
-
2013
- 2013-06-28 IN IN10680DEN2014 patent/IN2014DN10680A/en unknown
- 2013-06-28 EA EA201590124A patent/EA201590124A1/en unknown
- 2013-06-28 US US13/931,201 patent/US9040569B2/en not_active Expired - Fee Related
- 2013-06-28 CN CN201380034589.0A patent/CN104507918A/en active Pending
- 2013-06-28 EP EP13809282.0A patent/EP2867216A4/en not_active Withdrawn
- 2013-06-28 KR KR20157002571A patent/KR20150037946A/en not_active Application Discontinuation
- 2013-06-28 NZ NZ628880A patent/NZ628880A/en not_active IP Right Cessation
- 2013-06-28 JP JP2015520598A patent/JP2015524391A/en not_active Withdrawn
- 2013-06-28 WO PCT/US2013/048723 patent/WO2014005098A2/en active Application Filing
- 2013-06-28 BR BR112014032290A patent/BR112014032290A2/en not_active IP Right Cessation
- 2013-06-28 AU AU2013282286A patent/AU2013282286A1/en not_active Abandoned
- 2013-06-28 MX MX2014015340A patent/MX2014015340A/en unknown
- 2013-06-28 CA CA2877941A patent/CA2877941A1/en not_active Abandoned
- 2013-07-01 TW TW102123484A patent/TWI516283B/en not_active IP Right Cessation
-
2014
- 2014-12-10 ZA ZA2014/09073A patent/ZA201409073B/en unknown
- 2014-12-25 IL IL236476A patent/IL236476A0/en unknown
-
2015
- 2015-04-10 US US14/683,935 patent/US9504672B2/en not_active Expired - Fee Related
- 2015-05-15 HK HK15104634.7A patent/HK1203956A1/en unknown
- 2015-11-06 HK HK15110967.1A patent/HK1210163A1/en unknown
Also Published As
Publication number | Publication date |
---|---|
NZ628880A (en) | 2016-08-26 |
WO2014005098A3 (en) | 2014-02-27 |
EA201590124A1 (en) | 2015-06-30 |
US9040569B2 (en) | 2015-05-26 |
ZA201409073B (en) | 2016-08-31 |
US20150209328A1 (en) | 2015-07-30 |
IL236476A0 (en) | 2015-02-26 |
US9504672B2 (en) | 2016-11-29 |
KR20150037946A (en) | 2015-04-08 |
TW201416093A (en) | 2014-05-01 |
BR112014032290A2 (en) | 2017-06-27 |
CA2877941A1 (en) | 2014-01-03 |
EP2867216A2 (en) | 2015-05-06 |
WO2014005098A2 (en) | 2014-01-03 |
HK1210163A1 (en) | 2016-04-15 |
HK1203956A1 (en) | 2015-11-06 |
AU2013282286A1 (en) | 2015-01-22 |
JP2015524391A (en) | 2015-08-24 |
MX2014015340A (en) | 2015-03-05 |
US20140005239A1 (en) | 2014-01-02 |
CN104507918A (en) | 2015-04-08 |
TWI516283B (en) | 2016-01-11 |
EP2867216A4 (en) | 2015-12-09 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
EP2751060A4 (en) | Process for producing both biobased succinic acid and 2,5-furandicarboxylic acid | |
PL2791093T3 (en) | Process for the preparation of 2, 3, 3, 3 tetrafluoropropene | |
EA033455B1 (en) | Crystalline forms of substituted 5-fluoro-1h-pyrazolopyridines, processes for preparing same, use thereof for producing a medicament, medicament and method of treatment based thereof | |
PL2630108T3 (en) | Process for the preparation of 2,3,3,3 tetrafluoropropene | |
IL230635A (en) | 1,2,3,4-tetrahydroquinoline derivative useful for the treatment of diabetes | |
WO2012025944A3 (en) | Sitagliptin, salts and polymorphs thereof | |
IL216935A0 (en) | Process for the preparation of nacre mechano-structured by mechanosynthesis, mechano-structured nacre thus obtained and uses thereof | |
FR2962731B1 (en) | PROCESS FOR THE PREPARATION OF AMINO-BENZOYL-BENZOFURAN DERIVATIVES | |
WO2014072961A3 (en) | Polymorphic forms of suvoroxant | |
IN2014DN10680A (en) | ||
HK1198584A1 (en) | Process for the preparation of travoprost | |
WO2015068175A3 (en) | An improved process for the preparation of pazopanib or a pharmaceutically acceptable salt thereof | |
HK1199242A1 (en) | Process for the production of 1,3-butadiene 13- | |
EA201300647A1 (en) | OPTIMIZED SYNTHESIS OF PURE NONPOLYMORPHIC CRYSTALLINE YELLOW ACIDS WITH A PARTICLE SIZE | |
WO2010079045A3 (en) | Crystalline salt forms of flibanserine | |
NZ720340A (en) | Synthesis of trans-8-chloro-5-methyl-1 -[4-(pyridin-2-yloxy)-cyclohexyl]-5,6-dihydro-4h-2,3,5,10b-tetraaza-benzo[e]azulene and crystalline forms thereof | |
WO2015052568A3 (en) | Solid forms of curcumin and derivatives thereof | |
HK1223334A1 (en) | Process for the manufacture of implants or intermediate products of such implants as well as implants and intermediate products obtained by such process | |
WO2014178064A3 (en) | "an improved process for the preparation of fluvoxamine maleate" | |
SG11201405376TA (en) | CRYSTALLINE FORMS OF 5α-ANDROSTANE-3β, 5, 6β-TRIOL AND PREPARATION METHODS THEREOF | |
WO2011100282A3 (en) | Imatinib mesylate polymorphs | |
HK1206729A1 (en) | [3-heteroaryl-2-trifluoromethyl-propyl]-piperidin-1-yle or - morpholin-4-yle compounds as trpa1 antagonists for the treatment of respiratory diseases trpa1 [3--2--]- -1---4- | |
WO2013114397A3 (en) | Pharmaceutically acceptable salt of brinzolamide and composition thereof | |
WO2014102820A3 (en) | Rivaroxaban intermediate and preparation thereof | |
WO2015001565A3 (en) | "an improved process for the preparation of 3-aryloxy-3- phenylpropylamine and salt thereof" |